NewsBenzingaTakeda Announces New Data From VERDICT Showing That Treating Adults With Intravenous ENTYVIO To Achieve Corticosteroid-Free Disease Clearance Resulted In Significantly Longer Time To First Ulcerative Colitis-Related Complication, Reducing UC... Takeda Announces New Data From VERDICT Showing That Treating Adults With Intravenous ENTYVIO To Achieve Corticosteroid-Free Disease Clearance Resulted In Significantly Longer Time To First Ulcerative Colitis-Related Complication, Reducing UC... Benzinga 2026.10.19 09:53 (GMT+0) Open on Benzinga Other news JP Morgan Maintains Overweight on SpaceX, Raises Price Target to $500 Keefe, Bruyette & Woods Maintains Outperform on Dime Commercial, Raises Price Target to $49 Keefe, Bruyette & Woods Maintains Outperform on AppFolio, Raises Price Target to $255 BMO Capital Maintains Outperform on HealthEquity, Raises Price Target to $125 JP Morgan Maintains Neutral on Corning, Lowers Price Target to $165 BMO Capital Maintains Market Perform on Equifax, Raises Price Target to $175
